X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (14) 14
humans (12) 12
index medicus (12) 12
chemotherapy (11) 11
female (9) 9
middle aged (9) 9
male (8) 8
aged (7) 7
adult (5) 5
colorectal cancer (5) 5
colorectal neoplasms - drug therapy (5) 5
disease-free survival (5) 5
care and treatment (4) 4
drug therapy (4) 4
radiation (4) 4
radiotherapy (4) 4
aged, 80 and over (3) 3
analysis (3) 3
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
antineoplastic combined chemotherapy protocols - therapeutic use (3) 3
camptothecin - analogs & derivatives (3) 3
cancer (3) 3
carcinoma (3) 3
clinical trials (3) 3
colorectal neoplasms - pathology (3) 3
dosage and administration (3) 3
fluorouracil - administration & dosage (3) 3
metastases (3) 3
oxaliplatin (3) 3
patients (3) 3
prognosis (3) 3
radiotherapy, intensity-modulated - methods (3) 3
research (3) 3
surgery (3) 3
survival rate (3) 3
therapy (3) 3
abridged index medicus (2) 2
acneiform rash (2) 2
antibodies, monoclonal, humanized - adverse effects (2) 2
antineoplastic combined chemotherapy protocols - administration & dosage (2) 2
bevacizumab (2) 2
camptothecin - administration & dosage (2) 2
cetuximab (2) 2
cetuximab plus chemotherapy (2) 2
chemoradiation (2) 2
combined modality therapy (2) 2
cutaneous metastases (2) 2
esophageal cancer (2) 2
fatal outcome (2) 2
fluorouracil (2) 2
follow-up studies (2) 2
gemcitabine (2) 2
growth-factor-receptor (2) 2
hematology (2) 2
hematology, oncology and palliative medicine (2) 2
hepatocellular carcinoma (2) 2
imrt (2) 2
internal medicine (2) 2
kaplan-meier estimate (2) 2
liver neoplasms - drug therapy (2) 2
liver neoplasms - secondary (2) 2
management (2) 2
medicine (2) 2
medicine & public health (2) 2
metastatic colorectal-cancer (2) 2
neoplasm metastasis (2) 2
open-label (2) 2
organoplatinum compounds - administration & dosage (2) 2
organoplatinum compounds - adverse effects (2) 2
pancreatic cancer (2) 2
pathology (2) 2
phytomenadione (2) 2
prevention (2) 2
proportional hazards models (2) 2
stomatitis (2) 2
topical treatment (2) 2
treatment outcome (2) 2
trial (2) 2
tumor (2) 2
tumors (2) 2
1st-line therapy (1) 1
1st-line treatment (1) 1
3d conformal radiotherapy (1) 1
activated granulocytes (1) 1
acute hematologic toxicity (1) 1
acute toxicity (1) 1
acute toxicity; anal cancer; concomitant radiochemotherapy; imrt; late toxicity; radiation; radiotherapy; cancer research; oncology (1) 1
adenocarcinoma (1) 1
adenocarcinoma - drug therapy (1) 1
adenocarcinoma - genetics (1) 1
adenocarcinoma - mortality (1) 1
adenocarcinoma - pathology (1) 1
adenocarcinoma - radiotherapy (1) 1
adenocarcinoma - secondary (1) 1
adenocarcinoma - therapy (1) 1
administration, cutaneous (1) 1
advanced cholangiocarcinoma (1) 1
aflibercept (1) 1
anal cancer (1) 1
angiogenesis inhibitors - adverse effects (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 10/2014, Volume 371, Issue 17, pp. 1609 - 1618
In patients with metastatic colon cancer, fluorouracil, oxaliplatin, and irinotecan plus bevacizumab, as compared with fluorouracil and irinotecan plus... 
1ST-LINE TREATMENT | MEDICINE, GENERAL & INTERNAL | INFUSIONAL FLUOROURACIL | LEUCOVORIN | MANAGEMENT | PHASE-III | GUIDELINES | IRINOTECAN | OXALIPLATIN | CHEMOTHERAPY | FOLFIRI | Follow-Up Studies | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Bevacizumab | Fluorouracil - therapeutic use | Antibodies, Monoclonal, Humanized - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Neoplasm Metastasis - drug therapy | Colorectal Neoplasms - drug therapy | Adult | Female | Leucovorin - therapeutic use | Liver Neoplasms - secondary | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Antibodies, Monoclonal, Humanized - adverse effects | Camptothecin - adverse effects | Camptothecin - therapeutic use | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Colorectal Neoplasms - pathology | Organoplatinum Compounds - therapeutic use | Organoplatinum Compounds - adverse effects | Treatment outcome | Care and treatment | Analysis | Colorectal cancer | Dosage and administration | Leucovorin | Fluorouracil | Colorectal carcinoma | Diarrhea | Metastasis | Survival | Patients | Clinical outcomes | Metastases | Irinotecan | Stomatitis | Chemotherapy | Neurotoxicity | Oxaliplatin | Monoclonal antibodies | Vascular endothelial growth factor | Neutropenia | Index Medicus | Abridged Index Medicus
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2015, Volume 91, Issue 3, pp. 524 - 529
Journal Article
Cancer, ISSN 0008-543X, 02/2016, Volume 122, Issue 4, pp. 574 - 581
The combination of gemcitabine and oxaliplatin with panitumumab versus gemcitabine and oxaliplatin alone has been evaluated in a phase 2, randomized trial as a... 
KRAS | panitumumab | biliary cancer | chemotherapy | cholangiocarcinoma | gemcitabine and oxaliplatin (GEMOX) | GROWTH-FACTOR-RECEPTOR | GALLBLADDER CANCER | OPEN-LABEL | II TRIAL | CAPECITABINE | ADVANCED CHOLANGIOCARCINOMA | CETUXIMAB | THERAPY | ONCOLOGY | Adenocarcinoma - pathology | Prognosis | Proto-Oncogene Proteins p21(ras) - genetics | Humans | Middle Aged | Male | Organoplatinum Compounds - administration & dosage | Adult | Female | Adenocarcinoma - genetics | Bile Duct Neoplasms - genetics | Biliary Tract Neoplasms - drug therapy | Biliary Tract Neoplasms - genetics | Bile Duct Neoplasms - drug therapy | Biliary Tract Neoplasms - pathology | Bile Ducts, Intrahepatic - pathology | Deoxycytidine - administration & dosage | Gallbladder Neoplasms - genetics | Treatment Outcome | Adenocarcinoma - drug therapy | Disease-Free Survival | Cholangiocarcinoma - pathology | Gallbladder Neoplasms - drug therapy | Cholangiocarcinoma - drug therapy | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Cholangiocarcinoma - genetics | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Bile Ducts, Extrahepatic - pathology | Gallbladder Neoplasms - pathology | Bile Duct Neoplasms - pathology | Deoxycytidine - analogs & derivatives | Clinical trials | Usage | Dosage and administration | Gemcitabine | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
International Journal of Urology, ISSN 0919-8172, 10/2013, Volume 20, Issue 10, pp. 971 - 978
Journal Article
Frontiers in Oncology, ISSN 2234-943X, 2019, Volume 9, pp. 115 - 115
Background: Most of the patients with Pancreatic Ductal Adenocarcinoma (PDA) are not eligible for a curative surgical resection. For this reason there is an... 
Cancer subtypes | Glycolysis | Transcriptomic data | Metabolism | Pancreatic cancer | GLUTAMINE | DUCTAL ADENOCARCINOMA | glycolysis | TUMOR | FOXM1 | HYPOXIA | transcriptomic data | cancer subtypes | pancreatic cancer | ONCOLOGY | POOR-PROGNOSIS | metabolism | EXPRESSION | PROGRESSION | Care and treatment | Research | Genetic transcription
Journal Article
Cancer Investigation, ISSN 0735-7907, 7/2015, Volume 33, Issue 6, pp. 259 - 266
Journal Article
Clinical Colorectal Cancer, ISSN 1533-0028, 03/2014, Volume 13, Issue 1, pp. 62 - 67
Background Cetuximab is an effective option for the treatment of metastatic colorectal cancer in the first and subsequent lines of treatment; among its side... 
Acneiform rash | Prevention | Cetuximab plus chemotherapy | Topical treatment | Phytomenadione | MANAGEMENT | PLUS IRINOTECAN | PHASE-II | OXALIPLATIN | CHEMOTHERAPY | TOXICITIES | ONCOLOGY | GRADE
Journal Article
EUROPEAN JOURNAL OF ONCOLOGY, ISSN 1128-6598, 2013, Volume 18, Issue 2, pp. 93 - 98
Cutaneous metastases from hepatocellular carcinoma (HCC) are rare. We report an unusual case of metachronous double skin metastases to the left nostril and the... 
CHEST-WALL | ONCOLOGY | chemotherapy | hepatocellular carcinoma | cutaneous metastases
Journal Article